Myomo raises 2026 guidance as MyoPro adoption expands
Myomo reported Q2 revenue of $11.7 million, up 21%, and raised full-year guidance to $45 million–$47 million as clinical and referral channels expanded MyoPro adoption.
Evidence notes
- Second-quarter revenue increased 21% year over year to $11.7 million.
- Referral-network sources through MyoConnect and other channels generated 53% of quarterly revenue.
- Myomo raised full-year revenue guidance to $45 million–$47 million while continuing to expand clinical awareness and referrals for MyoPro.
Company context
Myomo develops MyoPro powered arm braces that use EMG sensing and motorized assistance to help people with arm and hand impairment regain functional movement.